StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
34
This year
3
Publishing Date
2024 - 03 - 27
1
2024 - 02 - 01
1
2024 - 01 - 25
1
2023 - 11 - 02
1
2023 - 10 - 26
1
2023 - 10 - 04
1
2023 - 09 - 15
1
2023 - 08 - 29
1
2023 - 05 - 17
1
2023 - 02 - 02
1
2023 - 01 - 06
1
2022 - 11 - 01
1
2022 - 10 - 28
1
2022 - 10 - 27
1
2022 - 09 - 09
1
2022 - 08 - 31
1
2022 - 07 - 13
1
2022 - 03 - 10
1
2022 - 02 - 02
1
2022 - 01 - 04
1
2021 - 12 - 14
1
2021 - 12 - 10
1
2021 - 09 - 17
1
2021 - 09 - 02
1
2021 - 07 - 30
1
2021 - 06 - 15
1
2021 - 06 - 04
1
2021 - 06 - 02
1
2021 - 05 - 20
1
2021 - 05 - 03
1
2021 - 04 - 29
1
2021 - 04 - 26
2
2021 - 04 - 09
1
Sector
Health technology
34
Manufacturing
3
N/a
1
Tags
Authorization
1
Biopharma
1
Biotech-beach
1
Biotechnology
1
Business
1
Cancer
1
Care
1
Clinical-trials-phase-ii
1
Companies
2
Covid
10
Covid-19
7
Drug
2
Earnings
1
Financial
5
Food
1
Genetic
1
Genetown
3
Global
3
Growth
3
Health
1
India
1
Infection
1
Infections
1
Influenza
4
Iot
1
Market
4
Merck
2
Mrna
1
N/a
19
New drug
1
News
1
People
2
Pharm-country
2
Pharma
1
Pharmaceutical
1
Positive
1
Product-news
2
Report
2
Repurposed
1
Research
2
Results
5
Rna-1083
1
Set
1
Spac
1
Space
2
Study
1
Technology
1
Therapeutics
3
Trials
1
Vaccine
17
Entities
Abbott laboratories
250
Abbvie inc.
211
Alnylam pharmaceuticals, inc.
78
Alphabet inc.
31
Amarin corporation plc
30
Amgen inc.
170
Astellas pharma inc
70
Astrazeneca plc
213
Aveo pharmaceuticals, inc.
20
Bausch health companies inc.
30
Baxter international inc.
45
Becton, dickinson and company
34
Biogen inc.
53
Biomarin pharmaceutical inc.
29
Biontech se
167
Blueprint medicines corporation
20
Boston scientific corporation
25
Bristol-myers squibb company
119
Byline bancorp, inc.
26
Clovis oncology, inc.
20
Csl ltd
22
Denali therapeutics inc.
22
Eli lilly and company
334
Endo international plc
20
Galapagos nv
35
Gilead sciences, inc.
64
Glaxosmithkline plc
334
Igm biosciences, inc.
37
Incyte corporation
121
Innate pharma s.a.
109
Innate pharma sa
81
Johnson & johnson
567
Karyopharm therapeutics inc.
25
Kymera therapeutics, inc.
29
Ligand pharmaceuticals incorporated
20
Medtronic plc
45
Mobiv acquisition corp
65
Moderna, inc.
34
Morphosys ag
35
Nektar therapeutics
42
Novartis ag
329
Novo nordisk a/s
139
Oncocyte corporation
31
Orange
49
Perrigo company
110
Pfizer, inc.
153
Provention bio, inc.
283
Ptc therapeutics, inc.
31
Rallybio corp
30
Rcf acquisition corp.
83
Regeneron pharmaceuticals, inc.
254
Sanofi
4531
Takeda pharmaceutical company limited
59
Teva pharmaceutical industries ltd
224
Therapeuticsmd, inc.
30
Thermo fisher scientific inc
43
Translate bio, inc.
21
Vaxart, inc.
32
Viatris inc.
87
Vir biotechnology, inc.
22
Symbols
ABB
1
ABBNY
1
ABLZF
1
ABT
1
ABUS
3
ADXS
1
ALKS
1
ALNY
6
ALPMF
2
ALPMY
2
AMGN
2
ARCT
3
ARVL
1
ARWR
2
ASMB
1
AUTL
1
AVRO
1
AXLA
12
AZN
5
AZNCF
1
BAX
2
BBIO
2
BIIB
1
BNTX
13
CDAK
12
CTLT
4
CVAC
6
DNLI
30
EVLO
20
FHTX
28
GBIO
4
GLAXF
5
GSK
7
IBM
2
ILMN
2
IONS
2
JNJ
19
LLY
3
MCRB
31
MRK
13
MRNA
349
NVAX
9
NVS
4
OMGA
23
PFE
7
REGN
4
RUBY
18
RVMD
5
SANA
30
SEER
2
SGMO
5
SGTX
12
SNY
34
SNYNF
22
SRPT
2
TAK
5
TBIO
4
TMO
3
WPP
2
XRAY
2
Exchanges
Nasdaq
34
Nyse
19
Crawled Date
2024 - 03 - 27
1
2024 - 02 - 01
1
2024 - 01 - 25
1
2023 - 11 - 02
1
2023 - 10 - 26
1
2023 - 10 - 04
1
2023 - 09 - 15
1
2023 - 08 - 29
1
2023 - 05 - 17
1
2023 - 02 - 02
1
2023 - 01 - 06
1
2022 - 11 - 01
1
2022 - 10 - 28
1
2022 - 10 - 27
1
2022 - 09 - 09
1
2022 - 08 - 31
1
2022 - 07 - 13
1
2022 - 03 - 10
1
2022 - 02 - 02
1
2022 - 01 - 04
1
2021 - 12 - 14
1
2021 - 12 - 10
1
2021 - 09 - 17
1
2021 - 09 - 02
1
2021 - 07 - 30
1
2021 - 06 - 15
1
2021 - 06 - 05
1
2021 - 06 - 02
1
2021 - 05 - 20
1
2021 - 05 - 03
1
2021 - 04 - 29
1
2021 - 04 - 26
2
2021 - 04 - 09
1
Crawled Time
00:20
1
02:00
1
07:00
1
08:00
1
11:00
4
12:00
6
12:15
1
13:00
1
13:15
1
14:00
2
14:15
1
15:00
2
16:00
4
17:00
2
18:00
1
20:00
1
21:00
2
23:00
2
Source
www.biospace.com
15
www.prnewswire.com
19
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Moderna, inc.
symbols :
Sny
save search
Moderna Advances Multiple Vaccine Programs to Late-Stage Clinical Trials
Published:
2024-03-27
(Crawled : 12:00)
- biospace.com/
SNYNF
|
$92.116
2.3K
|
Health Technology
|
-7.85%
|
O:
-0.26%
H:
0.0%
C:
0.0%
SNY
|
$46.24
0.96%
1.2M
|
Health Technology
|
-6.77%
|
O:
1.06%
H:
0.0%
C:
0.0%
MRNA
S
|
$103.28
-0.49%
550K
|
Health Technology
|
-3.37%
|
O:
2.02%
H:
1.41%
C:
0.92%
vaccine
trials
Merck Announces Fourth-Quarter and Full-Year 2023 Financial Results
Published:
2024-02-01
(Crawled : 23:00)
- biospace.com/
SNYNF
|
$92.116
2.3K
|
Health Technology
|
-8.8%
|
O:
-4.37%
H:
0.0%
C:
0.0%
MRK
|
$125.08
0.02%
1.8M
|
Health Technology
|
3.54%
|
O:
2.38%
H:
2.25%
C:
2.21%
SNY
|
$46.24
0.96%
1.2M
|
Health Technology
|
-10.32%
|
O:
-5.26%
H:
0.0%
C:
0.0%
MRNA
S
|
$103.28
-0.49%
550K
|
Health Technology
|
2.71%
|
O:
-0.15%
H:
0.1%
C:
-1.86%
HARP
|
$23.01
0.07%
6.6M
|
Health Technology
|
2.96%
|
O:
0.0%
H:
0.0%
C:
0.0%
merck
financial
results
Global mRNA-based Vaccines and Therapeutics Market is Projected to Grow Immensely During the Study Period (2019-2032) | DelveInsight
Published:
2024-01-25
(Crawled : 23:00)
- prnewswire.com
MTLHY
|
$29.93
1.1K
|
n/a
|
-2.09%
|
O:
-1.11%
H:
0.1%
C:
0.1%
SNYNF
|
$92.116
2.3K
|
Health Technology
|
-7.19%
|
O:
1.8%
H:
0.0%
C:
-1.82%
VRTX
|
$393.405
-0.19%
320K
|
Health Technology
|
-8.32%
|
O:
0.25%
H:
0.27%
C:
-0.2%
SLN
|
$21.51
1.22%
47K
|
Health Technology
|
11.84%
|
O:
4.32%
H:
0.0%
C:
-3.68%
SNY
|
$46.24
0.96%
1.2M
|
Health Technology
|
-8.08%
|
O:
0.5%
H:
0.0%
C:
0.0%
MRNA
S
|
$103.28
-0.49%
550K
|
Health Technology
|
0.95%
|
O:
0.72%
H:
0.34%
C:
-1.68%
MRUS
|
$41.17
2.13%
150K
|
Health Technology
|
18.21%
|
O:
0.35%
H:
2.81%
C:
-0.53%
ICLR
|
$291.76
-0.77%
120K
|
Health Technology
|
10.75%
|
O:
1.13%
H:
0.82%
C:
-0.74%
BNTX
|
$86.57
0.27%
1M
|
Health Technology
|
-10.9%
|
O:
-1.35%
H:
0.12%
C:
-0.83%
global
therapeutics
study
market
Moderna Reports Third Quarter 2023 Financial Results and Provides Business Updates
Published:
2023-11-02
(Crawled : 12:00)
- biospace.com/
SNY
|
$46.24
0.96%
1.2M
|
Health Technology
|
0.5%
|
O:
3.0%
H:
0.0%
C:
0.0%
MRNA
S
|
$103.28
-0.49%
550K
|
Health Technology
|
36.21%
|
O:
-15.55%
H:
13.91%
C:
10.69%
business
financial
results
Merck Announces Third-Quarter 2023 Financial Results
Published:
2023-10-26
(Crawled : 11:00)
- biospace.com/
MRK
|
$125.08
0.02%
1.8M
|
Health Technology
|
20.68%
|
O:
-0.51%
H:
4.0%
C:
2.38%
SNY
|
$46.24
0.96%
1.2M
|
Health Technology
|
-13.6%
|
O:
0.09%
H:
0.0%
C:
0.0%
MRNA
S
|
$103.28
-0.49%
550K
|
Health Technology
|
35.21%
|
O:
-0.04%
H:
0.64%
C:
-0.98%
merck
financial
results
Moderna Announces Positive Phase 1/2 Data from mRNA-1083, the Company's Combination Vaccine Against Influenza and COVID-19
Published:
2023-10-04
(Crawled : 12:00)
- biospace.com/
SNY
|
$46.24
0.96%
1.2M
|
Health Technology
|
-13.94%
|
O:
1.07%
H:
0.0%
C:
0.0%
MRNA
S
|
$103.28
-0.49%
550K
|
Health Technology
|
0.69%
|
O:
1.48%
H:
0.2%
C:
-0.33%
rna-1083
covid-19
vaccine
positive
influenza
RNA Therapeutics Market worth $18.0 billion | MarketsandMarkets
Published:
2023-09-15
(Crawled : 15:00)
- prnewswire.com
SNYNF
|
$92.116
2.3K
|
Health Technology
|
-14.98%
|
O:
1.53%
H:
0.0%
C:
0.0%
NVSEF
|
$93.6375
82K
|
Health Technology
|
10.49%
|
O:
0.79%
H:
0.0%
C:
0.0%
ALPMY
|
$9.34
690K
|
Manufacturing
|
-37.69%
|
O:
3.0%
H:
0.0%
C:
-3.43%
PFE
A
|
$25.35
-1.32%
23M
|
Health Technology
|
-24.77%
|
O:
-0.26%
H:
1.04%
C:
0.03%
NVS
|
$93.025
-0.19%
360K
|
Health Technology
|
-8.85%
|
O:
1.51%
H:
0.26%
C:
-0.72%
SRPT
|
$117.57
0.24%
130K
|
Health Technology
|
-2.03%
|
O:
-0.27%
H:
0.54%
C:
-0.84%
SNY
|
$46.24
0.96%
1.2M
|
Health Technology
|
-15.91%
|
O:
0.82%
H:
0.0%
C:
0.0%
MRNA
S
|
$103.28
-0.49%
550K
|
Health Technology
|
-8.0%
|
O:
0.16%
H:
2.0%
C:
1.42%
IONS
|
$41.375
-0.4%
490K
|
Health Technology
|
-4.81%
|
O:
-0.57%
H:
0.35%
C:
-1.11%
BNTX
|
$86.57
0.27%
1M
|
Health Technology
|
-24.14%
|
O:
0.17%
H:
0.48%
C:
-0.82%
ARWR
|
$23.32
-1.48%
210K
|
Health Technology
|
-22.5%
|
O:
0.16%
H:
0.46%
C:
-5.46%
ALNY
|
$147.2
0.33%
130K
|
Health Technology
|
-24.0%
|
O:
-0.74%
H:
2.42%
C:
-3.47%
therapeutics
market
Flagship Pioneering Announces Appointment of David Khougazian as Growth Partner
Published:
2023-08-29
(Crawled : 12:00)
- prnewswire.com
OMGA
|
$2.54
5.39%
150K
|
|
-33.43%
|
O:
1.66%
H:
9.24%
C:
6.52%
SANA
4
|
$8.345
-0.77%
290K
|
|
52.08%
|
O:
0.0%
H:
1.07%
C:
-2.35%
MCRB
|
$0.6076
-4.48%
1.7M
|
Health Technology
|
-82.13%
|
O:
-0.56%
H:
1.84%
C:
0.56%
SNY
|
$46.24
0.96%
1.2M
|
Health Technology
|
-14.76%
|
O:
0.34%
H:
0.0%
C:
0.0%
MRNA
S
|
$103.28
-0.49%
550K
|
Health Technology
|
-8.82%
|
O:
-0.07%
H:
2.36%
C:
1.97%
FHTX
|
$5.865
-2.74%
110K
|
Health Technology
|
-20.03%
|
O:
0.0%
H:
3.05%
C:
2.79%
DNLI
|
$17.125
-1.24%
500K
|
Health Technology
|
-23.85%
|
O:
0.09%
H:
1.18%
C:
0.66%
growth
Global mRNA Vaccine and Therapeutics Market Research Report 2023: Market to Decrease by a CAGR of 34.01% to 2028
Published:
2023-05-17
(Crawled : 02:00)
- prnewswire.com
SNY
|
$46.24
0.96%
1.2M
|
Health Technology
|
-15.43%
|
O:
-0.73%
H:
0.0%
C:
0.0%
MRNA
S
|
$103.28
-0.49%
550K
|
Health Technology
|
-17.04%
|
O:
-0.69%
H:
2.21%
C:
1.06%
BNTX
|
$86.57
0.27%
1M
|
Health Technology
|
-18.24%
|
O:
2.31%
H:
0.35%
C:
-2.67%
report
vaccine
mrna
research
global
therapeutics
market
Merck Announces Fourth-Quarter and Full-Year 2022 Financial Results
Published:
2023-02-02
(Crawled : 14:00)
- biospace.com/
ALPMY
|
$9.34
690K
|
Manufacturing
|
-36.68%
|
O:
1.22%
H:
0.0%
C:
-1.61%
MRK
|
$125.08
0.02%
1.8M
|
Health Technology
|
16.9%
|
O:
-2.77%
H:
1.72%
C:
-0.54%
SGEN
|
$228.74
0.1%
20M
|
Health Technology
|
64.53%
|
O:
-0.37%
H:
1.07%
C:
0.66%
SNY
|
$46.24
0.96%
1.2M
|
Health Technology
|
-5.52%
|
O:
-1.44%
H:
0.0%
C:
0.0%
MRNA
S
|
$103.28
-0.49%
550K
|
Health Technology
|
-40.45%
|
O:
-0.52%
H:
1.92%
C:
1.7%
financial
results
Worldwide Vaccines Industry to 2029 - Combination Vaccines Remain a Significant Growth Contributor to Vaccine Spaces
Published:
2023-01-06
(Crawled : 21:00)
- prnewswire.com
JNJ
|
$143.92
-0.37%
3.2M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
$20.2
510
|
Health Technology
|
Email alert
Add to watchlist
MRNA
S
|
$103.28
-0.49%
550K
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
$39.675
-0.69%
1.9M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
$46.24
0.96%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
$92.116
2.3K
|
Health Technology
|
Email alert
Add to watchlist
vaccine
growth
DelveInsight Evaluates a Robust RNA Interference Pipeline as Key 85+ Pharma Companies Set Foot in the RNA Interference Space
Published:
2022-11-01
(Crawled : 16:00)
- prnewswire.com
SNYNF
|
$92.116
2.3K
|
Health Technology
|
11.45%
|
O:
7.74%
H:
0.17%
C:
0.17%
JNJ
|
$143.92
-0.37%
3.2M
|
Health Technology
|
-17.19%
|
O:
-0.36%
H:
0.0%
C:
0.0%
LLY
|
$756.62
1.32%
1.5M
|
Health Technology
|
106.23%
|
O:
-4.49%
H:
3.81%
C:
1.95%
SNY
|
$46.24
0.96%
1.2M
|
Health Technology
|
6.43%
|
O:
0.23%
H:
0.0%
C:
0.0%
MRNA
S
|
$103.28
-0.49%
550K
|
Health Technology
|
-30.96%
|
O:
2.95%
H:
2.66%
C:
-0.1%
CVAC
|
$2.59
-2.81%
390K
|
Health Technology
|
-63.39%
|
O:
1.1%
H:
3.4%
C:
-1.36%
BNTX
|
$86.57
0.27%
1M
|
Health Technology
|
-37.27%
|
O:
4.54%
H:
4.25%
C:
0.13%
ALNY
|
$147.2
0.33%
130K
|
Health Technology
|
-29.21%
|
O:
1.06%
H:
2.53%
C:
1.75%
space
pharma
companies
set
$12+ Billion Influenza Vaccines Market to Grow at 7+% CAGR, Globally, by 2028 Lead by Quadrivalent Vaccines Segment with 88.36% Market Share in 2022 | The Insight Partners
Published:
2022-10-28
(Crawled : 11:00)
- prnewswire.com
SNYNF
|
$92.116
2.3K
|
Health Technology
|
10.38%
|
O:
3.33%
H:
0.74%
C:
-1.67%
GSK
|
$39.675
-0.69%
1.9M
|
Health Technology
|
22.1%
|
O:
0.89%
H:
1.3%
C:
0.79%
SNY
|
$46.24
0.96%
1.2M
|
Health Technology
|
9.79%
|
O:
2.57%
H:
0.0%
C:
0.0%
MRNA
S
|
$103.28
-0.49%
550K
|
Health Technology
|
-27.98%
|
O:
-0.88%
H:
5.85%
C:
5.69%
influenza
market
vaccine
Merck Announces Third-Quarter 2022 Financial Results
Published:
2022-10-27
(Crawled : 11:00)
- biospace.com/
MRK
|
$125.08
0.02%
1.8M
|
Health Technology
|
27.08%
|
O:
1.45%
H:
1.66%
C:
-0.1%
SNY
|
$46.24
0.96%
1.2M
|
Health Technology
|
10.16%
|
O:
0.34%
H:
0.0%
C:
0.0%
MRNA
S
|
$103.28
-0.49%
550K
|
Health Technology
|
-26.91%
|
O:
0.97%
H:
2.0%
C:
0.51%
financial
results
Global $12.27 Bn Influenza Vaccines Markets, 2022-2028: Strong Pipeline Candidates & Opportunities in Emerging Economies
Published:
2022-09-09
(Crawled : 12:00)
- prnewswire.com
GLAXF
|
$20.2
510
|
Health Technology
|
34.58%
|
O:
-1.6%
H:
6.13%
C:
6.13%
SNYNF
|
$92.116
2.3K
|
Health Technology
|
20.79%
|
O:
4.47%
H:
0.0%
C:
0.0%
GSK
|
$39.675
-0.69%
1.9M
|
Health Technology
|
26.79%
|
O:
1.4%
H:
0.06%
C:
-0.19%
SNY
|
$46.24
0.96%
1.2M
|
Health Technology
|
15.14%
|
O:
2.11%
H:
0.0%
C:
0.0%
MRNA
S
|
$103.28
-0.49%
550K
|
Health Technology
|
-26.54%
|
O:
0.54%
H:
0.43%
C:
0.17%
global
influenza
vaccine
Influenza Pipeline Looks Promising as 100+ Companies Working in the Domain, Assesses DelveInsight
Published:
2022-08-31
(Crawled : 16:00)
- prnewswire.com
SNYNF
|
$92.116
2.3K
|
Health Technology
|
15.64%
|
O:
0.75%
H:
1.98%
C:
1.98%
SNY
|
$46.24
0.96%
1.2M
|
Health Technology
|
11.36%
|
O:
1.1%
H:
0.0%
C:
0.0%
NVAX
|
$3.945
-1.13%
800K
|
Health Technology
|
-88.67%
|
O:
1.39%
H:
1.34%
C:
-7.48%
MRNA
S
|
$103.28
-0.49%
550K
|
Health Technology
|
-23.64%
|
O:
0.75%
H:
2.14%
C:
-3.42%
CDTX
|
$0.75
2.74%
350K
|
Health Technology
|
4.93%
|
O:
1.15%
H:
0.0%
C:
-3.37%
companies
influenza
Revolution Medicines Appoints Lorence Kim, M.D., Accomplished Health Care Industry Leader, to Board of Directors
Published:
2022-07-13
(Crawled : 12:00)
- biospace.com/
SNYNF
|
$92.116
2.3K
|
Health Technology
|
-9.11%
|
O:
-0.1%
H:
0.0%
C:
-2.06%
SNY
|
$46.24
0.96%
1.2M
|
Health Technology
|
-8.65%
|
O:
-1.38%
H:
0.0%
C:
0.0%
RVMD
S
|
$36.55
0.83%
180K
|
Health Technology
|
61.25%
|
O:
-2.8%
H:
7.41%
C:
5.9%
MRNA
S
|
$103.28
-0.49%
550K
|
Health Technology
|
-40.64%
|
O:
-3.41%
H:
4.6%
C:
1.4%
care
health
New Variants Throw the Spotlight on Booster Shots of COVID-19 Vaccines - According to New Research from StrategyR
Published:
2022-03-10
(Crawled : 15:00)
- prnewswire.com
SNYNF
|
$92.116
2.3K
|
Health Technology
|
-7.23%
|
O:
2.52%
H:
1.67%
C:
1.67%
JNJ
|
$143.92
-0.37%
3.2M
|
Health Technology
|
-15.01%
|
O:
-0.85%
H:
0.0%
C:
0.0%
SNY
|
$46.24
0.96%
1.2M
|
Health Technology
|
-10.09%
|
O:
-0.12%
H:
0.0%
C:
0.0%
NVAX
|
$3.945
-1.13%
800K
|
Health Technology
|
-94.95%
|
O:
-1.99%
H:
2.84%
C:
0.35%
MRNA
S
|
$103.28
-0.49%
550K
|
Health Technology
|
-27.16%
|
O:
-2.09%
H:
0.95%
C:
0.01%
covid-19
research
covid
vaccine
Global COVID-19 Vaccines Market Report 2022: Leading Vaccine Companies Stress on Booster Dose
Published:
2022-02-02
(Crawled : 21:00)
- prnewswire.com
JNJ
|
$143.92
-0.37%
3.2M
|
Health Technology
|
-15.05%
|
O:
1.26%
H:
0.0%
C:
0.0%
SNY
|
$46.24
0.96%
1.2M
|
Health Technology
|
-11.99%
|
O:
-0.06%
H:
0.0%
C:
0.0%
NVAX
|
$3.945
-1.13%
800K
|
Health Technology
|
-95.72%
|
O:
-4.8%
H:
4.69%
C:
-0.33%
MRNA
S
|
$103.28
-0.49%
550K
|
Health Technology
|
-39.42%
|
O:
-3.66%
H:
3.05%
C:
-0.68%
covid-19
covid
report
vaccine
As Omicron Strain Fuels Fresh Waves of Infections Across the Globe, Mutating Coronavirus is the New Pandemic Challenge in 2022
Published:
2022-01-04
(Crawled : 17:00)
- prnewswire.com
JNJ
|
$143.92
-0.37%
3.2M
|
Health Technology
|
-15.11%
|
O:
0.51%
H:
0.0%
C:
0.0%
SNY
|
$46.24
0.96%
1.2M
|
Health Technology
|
-9.49%
|
O:
-2.03%
H:
0.0%
C:
0.0%
NVAX
|
$3.945
-1.13%
800K
|
Health Technology
|
-97.21%
|
O:
-2.03%
H:
1.27%
C:
-1.11%
MRNA
S
|
$103.28
-0.49%
550K
|
Health Technology
|
-55.84%
|
O:
-1.15%
H:
0.0%
C:
0.0%
infection
infections
← Previous
1
2
Next →
Gainers vs Losers
64%
36%
Top 10 Gainers
INVO
|
$2.78
265.79%
200M
|
Health Technology
RYDE
|
$4.66
70.7%
410K
|
n/a
EDBL
|
$7.4
62.64%
12M
|
GRTX
|
$0.237
39.41%
13M
|
Health Technology
VNDA
|
$5.28
30.37%
21M
|
Health Technology
VIRX
|
$0.912
27.59%
170K
|
Manufacturing
WISA
4
|
$7.72
26.56%
51M
|
Electronic Technology
TCON
|
$2.135
24.85%
440K
|
Health Technology
AGFY
|
$0.37
24.2%
28M
|
BCAN
|
$1.085
23.73%
7.4M
|
Construction
Your saved searches
Save your searches and get alerts when important news are released.